EMEakkarin Mekangkul

Eakkarin Mekangkul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eakkarin Mekangkul has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of oral nutritional supplement on growth and body composition in malnutrition at risk and malnourished children: MARVEL study, a multi-center randomized controlled trial

    by Orapa Suteerojntrakool, Patcharapa Thaweekul, Suchaorn Saengnipanthkul, Kamolmart Wannaphahoon, Eakkarin Mekangkul, Sirinuch Chomtho

    Purpose: This study investigated the effect of oral nutritional supplement (ONS) on growth and body composition in undernourished children. Methods: Thai children aged 1–6 years with weight-for-height (WFH) z-scores between − 1 SD and − 3 SD were randomized (1:1) to receive either dietary counselling alone (DC group) or counselling plus 420 mL/day of a cow’s milk–based ONS (1 kcal/mL; energy distribution: 10% protein, 49% carbohydrate, 41% fat; fortified with calcium, vitamin D, iron, and zinc) for 3 months. Weight and height were measured at baseline, 1, and 3 months and compared with WHO standards. Body composition was assessed via bioelectrical impedance analysis in children aged ≥ 3 years old at the same period. Results: A total of 159 children (78 DC and 81 ONS), with mean ages (95% CI) of 3.5 (3.15–3.90) and 3.49 (3.10–3.90) years, were included. After 3 months, the ONS group demonstrated higher gains in weight, height, weight-for-age (WFA) and weight-for-height (WFH) z-score compared to the DC group [mean difference (95% CI): weight 0.16 (0.04–0.28) kg; height: 0.42 (0.05–0.79) cm; WFA z-score: 0.10 (0.01–0.18); WFH z-score: 0.13 (− 0.02 to 0.27)]. Gains in fat-free mass were higher with ONS at both 1 and 3 months [mean difference (95%CI): 0.26 (0.01–0.50) and 0.36 (0.10–0.63) kg]. Soft lean mass gain was also significantly greater in the ONS group at 3 months [0.39 (0.11–0.68) kg]. Conclusions: ONS combined with dietary counselling improved growth and fat-free mass, supporting its role in promoting healthier body composition and long-term metabolic health. TCTR20220908004. Category of study: Randomized controlled trials.

  • Open Access

    Human milk macronutrient composition and intake in relation to preterm infant growth: a cohort study

    by Eakkarin Mekangkul, Chonnikant Visuthranukul, Anongnart Sirisabya, Thaninee Chitsinchayakul, Santi Punnahitananda, Sirinuch Chomtho

    Background: Individualized targeted fortification based on human milk (HM) analysis reportedly achieves optimal outcomes in preterm infants. Therefore, understanding the effects of macronutrients in HM on preterm infant growth is essential.Purpose: This study aimed to determine the association between HM macronutrients and the growth of preterm infants. We also compared macronutrient intake data obtained from an HM analyzer (HMA)–based calculation with those derived from a reference-based calculation.Methods: This prospective-retrospective cohort study included infants born at 34 weeks' gestation or less. HM samples were collected weekly for up to 4 weeks or until discharge, whichever occurred first. Clinical outcomes were recorded. The macronutrient composition was analyzed using midinfrared HMA. Associations were determined using a linear regression model.Results: Of 121 preterm infants, 65 (51.2%) were male. A total of 200 HM samples were analyzed. Fat composition showed a significant positive association with weight gain velocity, with an adjusted unstandardized coefficient (aB) of 3.07 (95% confidence interval [CI], 0.22–5.93). Total protein and fat intakes were positively associated with weight gain (aB, 3.41; 95% CI, 0.83–5.98; and aB, 7.07; 95% CI, 1.73–12.42, respectively). When using the HMA-based calculation, protein intake was lower and carbohydrate intake was higher throughout the 4-week period compared with those obtained based on the reference-based calculation.Conclusion: Higher protein and fat intakes could potentially enhance weight gain in preterm infants. These findings provide further evidence to support the concept of individualized HM fortification. Our findings underscore the importance of using HMA-based methods to calculate macronutrient intakes among preterm infants.

  • Preservation of Anti-SARS-CoV-2 Neutralizing Antibodies in Breast Milk: Impact of Maternal COVID-19 Vaccination and Infection

    by Orapa Suteerojntrakool, Eakkarin Mekangkul, Duangporn Maitreechit, Siriporn Khabuan, Pimpayao Sodsai, Nattiya Hirankarn, Rungtip Thumbovorn, Sirinuch Chomtho

    Objectives: To investigate specific immunoglobulin A (sIgA), specific immunoglobulin G (sIgG), and neutralizing antibodies (NAbs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in breast milk and compare immunity in mothers with hybrid immunity (infection and vaccination) versus those solely vaccinated (coronavirus disease [COVID]-naïve). Methods: A longitudinal study was conducted among lactating mothers who received at least two doses of the coronavirus disease 2019 (COVID-19) vaccine or tested positive for SARS-CoV-2. Details of vaccination and infection were collected through questionnaires and interviews. Fifteen milliliters of breast milk samples, self-collected at 1, 3, and 6 months postvaccination or infection, were sent to analysis for sIgA, sIgG, and NAbs using enzyme-linked immunosorbent assay. Results: In total, 119 lactating mothers (202 milk samples) were enrolled; 82 participants had hybrid immunity, and 32 were COVID-19-naïve. Two-thirds received a combination of different vaccines and booster shots. Breast milk retained sIgA, sIgG, and NAbs for up to 6 months post-COVID vaccination or infection. At 3 months, mothers with hybrid immunity had significantly higher sIgA and NAbs compared with COVID-naïve mothers (geometric mean [95% confidence interval (CI)] of sIgA 2.72 [1.94–3.8] vs. 1.44 [0.83–2.48]; NAbs 86.83 [84.9–88.8] vs. 81.28 [76.02–86.9]). No differences in sIgA, sIgG, and NAbs were observed between lactating mothers receiving two, three, or more than or equal to three doses, regardless of hybrid immunity or COVID-naïve status. Conclusion: sIgA, sIgG, and NAbs against SARS-CoV-2 in breast milk sustained for up to 6 months postimmunization and infection. Higher immunity was found in mothers with hybrid immunity. These transferred immunities confirm in vitro protection, supporting the safety of breastfeeding during and after COVID-19 vaccination or infection.